PDT for cancers of the head and neck

被引：8
作者：
Allison, Ron R. [1 ]
Sibata, Claudia [1 ]
Gay, Hiram [1 ]
机构：
[1] E Carolina Univ, Brody Sch Med, Leo Jenkins Canc Ctr, PDT Ctr,Dept Radiat Oncol,Photodynam Therapy Ctr, Greenville, NC 27834 USA
来源：
PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY | 2009年 / 6卷 / 01期
关键词：
SQUAMOUS-CELL CARCINOMA; TWICE-DAILY REIRRADIATION; PHASE-II; PHOTODYNAMIC THERAPY; RECURRENT HEAD; CHEMOTHERAPY; PACLITAXEL; CISPLATIN; TRIAL;
D O I：
10.1016/j.pdpdt.2009.03.003
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1 / 2
页数：2
相关论文
共 9 条
  • [1] Clinical photodynamic therapy of head and neck cancers-A review of applications and outcomes
    Allison, R. R.
    Cuenca, R. E.
    Downie, G. H.
    Camnitze, P.
    Brodish, B.
    Sibata, C. H.
    [J]. PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2005, 2 (03) : 205 - 222
  • [2] mTHPC-mediated photodynamic therapy in patients with advanced, incurable head and neck cancer: A multicenter study of 128 patients
    D'Cruz, AK
    Robinson, MH
    Biel, MA
    [J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2004, 26 (03): : 232 - 240
  • [3] Reirradiation alternating with docetaxel and cisplatin in inoperable recurrence of head-and-neck cancer:: A prospective phase I/II trial
    Hehr, T
    Classen, J
    Belka, C
    Welz, S
    Schäfer, J
    Koitschev, A
    Bamberg, M
    Budach, W
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 61 (05): : 1423 - 1431
  • [4] Toxicity and outcome analysis of patients with recurrent head and neck cancer treated with hyperfractionated split-course reirradiation and concurrent cisplatin and paclitaxel chemotherapy from two prospective phase I and II studies
    Kramer, NM
    Horwitz, EM
    Cheng, J
    Ridge, JA
    Feigenberg, SJ
    Cohen, RB
    Nicolaou, N
    Sherman, EJ
    Babb, JS
    Damsker, JA
    Langer, CJ
    [J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2005, 27 (05): : 406 - 414
  • [5] A phase II study of primary reirradiation in squamous cell carcinoma of head and neck
    Langendijk, Johannes A.
    Kasperts, Nicolien
    Leemans, Charles R.
    Doornaert, Patricia
    Slotman, Ben J.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2006, 78 (03) : 306 - 312
  • [6] Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: Results of radiation therapy oncology group protocol 9911
    Langer, Corey J.
    Harris, Jonathan
    Horwitz, Eric M.
    Nicolaou, Nicos
    Kies, Merrill
    Curran, Walter
    Wong, Stuart
    Ang, Kian
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (30) : 4800 - 4805
  • [7] Interstitial photodynamic therapy as salvage treatment for recurrent head and neck cancer
    Lou, PJ
    Jäger, HR
    Jones, L
    Theodossy, T
    Bown, SG
    Hopper, C
    [J]. BRITISH JOURNAL OF CANCER, 2004, 91 (03) : 441 - 446
  • [8] Twice-daily reirradiation for recurrent and second primary head-and-neck cancer with gemcitabine, paclitaxel, and 5-fluorouracil chemotherapy
    Milano, MT
    Vokes, EE
    Salama, JK
    Stenson, KM
    Kao, J
    Witt, ME
    Mittal, BB
    Argiris, A
    Weichselbaum, RR
    Haraf, DJ
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 61 (04): : 1096 - 1106
  • [9] Final report of rtog 9610, a multi-institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neck
    Spencer, Sharon A.
    Harris, Jonathan
    Wheeler, Richard H.
    Machtay, Mitchell
    Schultz, Christopher
    Spanos, William
    Rotman, Marvin
    Meredith, Ruby
    Ang, Kie-Kian
    [J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2008, 30 (03): : 281 - 288
1